Zuclopenthixol decanoate

• Description:

  Zuclopenthixol decanoate is a long-acting agent for schizophrenia and other serious mental illnesses research[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302

• Target:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/zuclopenthixol-decanoate.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CCCCCCCCCC(OCCN1CCN(CC1)CC/C=C2C3=C(C=CC(Cl)=C3)SC4=C\2C=CC=C4)=O

• Molecular Formula:

  C32H43ClN2O2S

• Molecular Weight:

  555.21

• Precautions:

  P264-P270-P330-P501

• References & Citations:

  [1]Manzaneque JM, et al. An ethopharmacological assessment of the effects of zuclopenthixol on agonistic interactions in male mice. Methods Find Exp Clin Pharmacol. 1999 Jan-Feb;21 (1) :11-5. |[2]E Coutinho, et al. Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses. Cochrane Database Syst Rev. 2000;1999 (2) :CD001164.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [64053-00-5]